English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/61831
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora

AuthorsGómez-Garre, Pilar; Gutiérrez-Delicado, Eva; Gómez-Abad, Cristina; Morales-Corraliza, José; Villanueva, Vicente E.; Rodríguez de Córdoba, Santiago ; Larrauri, Javier; Gutiérrez, Manuel Carolina; Berciano, Javier; Serratosa, José María
Issue DateApr-2007
PublisherAmerican Academy of Neurology
CitationNeurology 68(17):1369-1373(2007)
AbstractBackground: Lafora disease (LD; progressive myoclonus epilepsy type 2; EPM2) is an autosomal recessive disorder caused by mutations in the EPM2A and EPM2B genes. LD is characterized by the presence of strongly PAS-positive intracellular inclusions (Lafora bodies) in several tissues. Glycogen storage disease type IV (GSD-IV; Andersen disease) is an autosomal recessive disorder characterized by cirrhosis leading to severe liver failure. GSD-IV has been associated with mutations in the glycogen branching enzyme gene (GBE). Histopathologic changes of the liver in both diseases show an identical appearance, although cirrhosis has never been described in patients with LD. We report a LD family in which the proband presented severe liver failure at onset of the disease. Methods: Clinical histories, physical and neurologic examination, laboratory tests, EEGs, MRI of the brain, and liver or axillary skin biopsies were performed in the two affected siblings. The diagnosis was confirmed by molecular genetic analysis of the EPM2A, EPM2B, and GBE genes and loci. Results: During the first decade of life, abnormalities in liver function tests were detected in the two affected siblings. The proband's liver dysfunction was severe enough to require liver transplantation. Subsequently, both sibs developed LD. Mutation analysis of EPM2A revealed a homozygous Arg241stop mutation in both patients. Conclusions: This is the first description of severe hepatic dysfunction as the initial clinical manifestation of LD. The phenotypic differences between the two affected siblings suggest that modifier genes must condition clinical expression of the disease outside the CNS
Description5 páginas, 2 figuras -- PAGS nros. 1369-1373
Publisher version (URL)http://dx.doi.org/10.1212/01.wnl.0000260061.37559.67
URIhttp://hdl.handle.net/10261/61831
DOI10.1212/01.wnl.0000260061.37559.67
ISSN0028-3878
E-ISSN1526-632X
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
Neurology_de Córdoba_2007.pdf1,61 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.